Lupus Peer-to-Peer Early Education Program Expands
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...
lupus therapeutics
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...
Championing Patient Power in Lupus
Dr. Stacie Bell came to LRA’s clinical research affiliate Lupus Therapeutics (LT) one year ago to help fulfill the...
LRA Highlights Groundbreaking Lupus Research at ACR Convergence 2023
This information is brought to you by the Lupus Research Alliance and Lupus Therapeutics and is not sponsored by, nor a part...
Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with the biopharmaceutical company Nkarta,...
To Increase Diversity in Lupus Clinical Research, Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia
NEW YORK, NY, June 29, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, launched...
Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network
NEW YORK, NY, June 2, 2023 — Lupus Research Alliance clinical research affiliate Lupus Therapeutics will collaborate with Novartis...
Investigational CAR T Cell Gets Fast Tracked by U.S. FDA
May 1, 2023
The LRA and our clinical arm Lupus Therapeutics are pleased to share good news from Cabaletta Bio,...
Lupus Research Alliance Appoints New Executive Vice President of Clinical Research Affiliate Lupus Therapeutics
NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) announced the appointment of Stacie J. Bell, PhD...
Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population
NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at...
Long-time Supporter LADA Donates $150,000 to LRA-Funded Research
August 29, 2022
Big thanks go to the Lupus and Allied Diseases Association, Inc. (LADA) for their donation of $150,000...
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...